Discovery of a broadly-neutralizing human antibody that can rescue mice challenged with neurotoxin-rich snake venoms
Ledsgaard, L.; Wade, J.; Boddum, K.; Oganesyan, I.; Harrison, J.; Jenkins, T. P.; Villar, P.; Leah, R. A.; Zenobi, R.; McCafferty, J.; Lomonte, B.; Gutierrez, J. M.; Laustsen, A. H.; Karatt-Vellatt, A.
Show abstract
Snakebite envenoming continues to claim many lives across the globe, necessitating the development of improved therapies. To this end, human monoclonal antibodies may possess advantages over current plasma-derived antivenoms by offering superior safety and improved neutralization capacity. However, as new antivenom products may need to be polyvalent, i.e., target multiple different snake species, without dramatically increasing dose or cost of manufacture, such monoclonal antibodies need to be broadly-neutralizing. Here, we report the establishment of a pipeline for the discovery of high affinity broadly-neutralizing human monoclonal antibodies. We further demonstrate its utility by discovering an antibody that can prevent lethality induced by N. kaouthia whole venom at an unprecedented low molar ratio of one antibody per toxin, and which also prolongs survival of mice injected with Dendroaspis polylepis or Ophiophagus hannah whole venoms.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Towards middle-up analysis of polyclonal antibodies: subclass-specific N-glycosylation profiling of murine immunoglobulin G (IgG) by means of HPLC-MS 92%
- The effect of terminal globular domains on the response of recombinant mini-spidroins to fiber spinning triggers 92%
- Identification of Chlorophyll a-b Binding Protein AB96 as a novel TGFbeta1 binding agent. 92%
Similar papers in this journal
- A combination of two small molecule toxin inhibitors provides pancontinental preclinical efficacy against viper snakebite 95%
- SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface 94%
- Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes 93%
Similar papers in this journal
- Exploring the utility of ssDNA aptamers directed against snake venom toxins as new therapeutics for tropical snakebite envenoming 95%
- Identification and characterization of novel proteins from Arizona bark scorpion venom that inhibit Nav1.8, a voltage-gated sodium channel regulator of pain signaling 94%
- A wolf in another wolf's clothing. Post-genomic regulation dictates venom profiles of medically-important cryptic kraits in India 94%
Similar papers in this journal
- Antigenic Divergence of Cobra Short-chain α-Neurotoxins: Implications for Regional Antivenom Effectiveness in Southeast Asia 95%
- Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: results of preclinical efficacy testing 94%
- High throughput screening and identification of coagulopathic snake venom proteins and peptides using nanofractionation and proteomics approaches 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.